AU5802490A - Derivatized dtpa complexes, pharmaceutical agents containing these compounds, their use, and processes for their production - Google Patents

Derivatized dtpa complexes, pharmaceutical agents containing these compounds, their use, and processes for their production

Info

Publication number
AU5802490A
AU5802490A AU58024/90A AU5802490A AU5802490A AU 5802490 A AU5802490 A AU 5802490A AU 58024/90 A AU58024/90 A AU 58024/90A AU 5802490 A AU5802490 A AU 5802490A AU 5802490 A AU5802490 A AU 5802490A
Authority
AU
Australia
Prior art keywords
represent
hydrogen atom
compounds
pharmaceutical agents
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU58024/90A
Other versions
AU637111B2 (en
Inventor
Heinz Dr. Gries
Johannes Dr. Platzek
Heribert Dr. Schmitt-Willich
Gabriele Dr. Schuhmann-Giampieri
Hubert Dr. Vogler
Hans-Joachim Dr. Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6384290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5802490(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering AG filed Critical Schering AG
Publication of AU5802490A publication Critical patent/AU5802490A/en
Application granted granted Critical
Publication of AU637111B2 publication Critical patent/AU637111B2/en
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94Bismuth compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compounds of the general formula <IMAGE> in which Z<1> and Z<2> each represent a hydrogen atom or the radical -(CH2)m-(C6H4)q-(O)k-(CH2)n(C6H4) l-(O)r-R, in which m and n denote the figures 0 - 20, k, l, q and r denote the figures 0 and 1 and R denotes a hydrogen atom, an unsubstituted or OR<1>-substituted C1-C6-alkyl radical or a CH2COOR<1> group where R<1> denotes a hydrogen atom, a C1-C6-alkyl radical or a benzyl group, X represents a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21 - 29, 42, 44 or 57 - 83, with the proviso that at least two of the substituents X represent a metal ion equivalent in which one of the substituents Z<1> and Z<2> represents a hydrogen atom and the other does not represent a hydrogen atom, in which - if n and l each represent the figure 0 - k and r do not simultaneously each denote the figure 1, in which Z<1> or Z<2> do not represent -CH2-C6H4-O-CH2-COOCH2C6H5 or CH2-C6H4-O-(CH2)5-COOCH2C6H5 and in which -(O)r-R does not represent -OH, and their salts with inorganic and/or organic bases, amino acids or amino acid amides, are useful pharmaceutical agents.
AU58024/90A 1989-06-30 1990-06-29 Derivatized dtpa complexes, pharmaceutical agents containing these compounds, their use, and processes for their production Expired AU637111B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3922005 1989-06-30
DE3922005A DE3922005A1 (en) 1989-06-30 1989-06-30 DERIVATIVED DTPA COMPLEXES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
AU5802490A true AU5802490A (en) 1991-01-03
AU637111B2 AU637111B2 (en) 1993-05-20

Family

ID=6384290

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58024/90A Expired AU637111B2 (en) 1989-06-30 1990-06-29 Derivatized dtpa complexes, pharmaceutical agents containing these compounds, their use, and processes for their production

Country Status (24)

Country Link
EP (1) EP0405704B1 (en)
JP (1) JP2603357B2 (en)
KR (1) KR100190808B1 (en)
AT (1) ATE115546T1 (en)
AU (1) AU637111B2 (en)
CA (1) CA2020142C (en)
CZ (1) CZ277926B6 (en)
DD (1) DD296276B5 (en)
DE (3) DE3922005A1 (en)
DK (1) DK0405704T3 (en)
ES (1) ES2066113T3 (en)
FI (1) FI102168B1 (en)
HK (1) HK1002810A1 (en)
HU (1) HU210208B (en)
IE (1) IE65676B1 (en)
IL (1) IL94818A (en)
NL (1) NL300182I2 (en)
NO (2) NO179203C (en)
NZ (1) NZ234295A (en)
PT (1) PT94541B (en)
RU (1) RU2086554C1 (en)
TW (1) TW219356B (en)
UA (1) UA27275C2 (en)
ZA (1) ZA905129B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (en) 1990-04-06 1991-10-10 Schering Ag DTPA MONOAMIDES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
DE4302287A1 (en) * 1993-01-25 1994-07-28 Schering Ag Derivatized DTPA complexes, pharmaceutical compositions containing these compounds, their use and processes for their preparation
DE4302289A1 (en) * 1993-01-25 1994-07-28 Schering Ag Process for the preparation of C-substituted diethylenetriamines
DE4341724A1 (en) * 1993-12-03 1995-06-08 Schering Ag Pharmaceutical compositions containing haloaryl-substituted metal complexes, their use in diagnostics, and methods for producing the complexes and compositions
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
CZ166797A3 (en) * 1994-11-30 1997-11-12 Schering Ag Application of metal complexes as liver and gallbladder x-ray diagnostic agents
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
TW319763B (en) 1995-02-01 1997-11-11 Epix Medical Inc
CA2212162A1 (en) * 1995-02-09 1996-08-15 Schering Aktiengesellschaft Liposomes that contain contrast media for the visualization of intravascular space
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
JP2759627B2 (en) * 1995-07-21 1998-05-28 東北大学長 Non-ester bondable DTPA derivative and method for producing the same
DE19641197C2 (en) * 1996-09-24 1999-02-18 Schering Ag Ion pairs and their use as contrast agents
DE19646762B4 (en) * 1996-11-04 2004-05-13 Schering Ag Use of metal compounds for the production of agents for radiotherapy of tumors
DE19712012A1 (en) * 1997-03-13 1998-09-24 Schering Ag Ethoxy:benzyl-di:ethylene tri:amine penta:acetic acid preparation
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
FR2867473B1 (en) 2004-03-12 2006-06-23 Guerbet Sa PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI
KR100749087B1 (en) * 2006-06-02 2007-08-14 경북대학교 산학협력단 New dtpa-bis-amide ligands and gd-complexes thereof
SE533165C2 (en) * 2008-06-13 2010-07-13 Chemseq Internat Ab Chemical and process for the complex bonding of metal ions, which are at least divalent
EP2338874A1 (en) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
DE102010023890A1 (en) 2010-06-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecanedioic acid comprises hydrolyzing 3,6,9-triaza-3,6,9-tris(tert-butoxy-carbonylmethyl)-4-(ethoxybenzyl)-undecanedioic acid-ditert-butylester and acidifying
WO2011154333A2 (en) 2010-06-11 2011-12-15 Bayer Pharma Aktiengesellschaft Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist®
CN104761461A (en) * 2014-09-09 2015-07-08 山东富创医药科技有限公司 Preparation method of novel gadoxetate disodium intermediate
WO2017208258A1 (en) * 2016-05-30 2017-12-07 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium)
JP6867639B2 (en) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 Combined nonionic iodine contrast agent
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE3869251D1 (en) * 1987-07-16 1992-04-23 Nycomed As AMINOPOLYCARBONIC ACIDS AND THEIR DERIVATIVES.
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (en) * 1987-08-24 1989-03-16 Schering Ag MULTI-CORE SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
TW219356B (en) 1994-01-21
HU904040D0 (en) 1990-12-28
CZ277926B6 (en) 1993-06-16
KR100190808B1 (en) 1999-06-01
HU210208B (en) 1995-02-28
JP2603357B2 (en) 1997-04-23
CA2020142C (en) 2001-04-17
ES2066113T3 (en) 1995-03-01
PT94541A (en) 1991-02-08
PT94541B (en) 1997-02-28
JPH03215457A (en) 1991-09-20
FI102168B (en) 1998-10-30
DD296276B5 (en) 1995-11-02
CA2020142A1 (en) 1990-12-31
IL94818A (en) 1996-05-14
IL94818A0 (en) 1991-04-15
NZ234295A (en) 1993-02-25
RU2086554C1 (en) 1997-08-10
EP0405704B1 (en) 1994-12-14
NO902925L (en) 1991-01-02
DE122004000051I2 (en) 2011-12-29
IE902299L (en) 1990-12-30
AU637111B2 (en) 1993-05-20
DE3922005A1 (en) 1991-01-10
HK1002810A1 (en) 1998-09-18
NL300182I2 (en) 2005-08-01
FI903295A0 (en) 1990-06-29
NO179203B (en) 1996-05-20
CS9003174A2 (en) 1991-11-12
ZA905129B (en) 1991-04-24
KR910000134A (en) 1991-01-29
HUT54622A (en) 1991-03-28
NO179203C (en) 1996-08-28
DK0405704T3 (en) 1995-02-20
IE902299A1 (en) 1991-01-16
NL300182I1 (en) 2005-06-01
ATE115546T1 (en) 1994-12-15
DE59007987D1 (en) 1995-02-02
IE65676B1 (en) 1995-11-15
DE122004000051I1 (en) 2005-04-21
EP0405704A2 (en) 1991-01-02
NO902925D0 (en) 1990-06-29
FI102168B1 (en) 1998-10-30
NO2005013I2 (en) 2006-06-19
EP0405704A3 (en) 1991-03-27
UA27275C2 (en) 2000-09-15

Similar Documents

Publication Publication Date Title
AU637111B2 (en) Derivatized dtpa complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
HK1002811A1 (en) 1,4,7,10-Tetraazacyclododecane-buryltriols process for their preparation and pharmaceutical agents containing these compounds
AU7418691A (en) DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production
ES2073006T3 (en) SEQUESTERS ASSOCIATED WITH CASCADA POLYMERS, THEIR COMPLEXES AND CONJUGATES, PROCESS FOR THEIR OBTAINING AND THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM.
IL89657A0 (en) Mesotetraphenylporphyrin complex derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
NO174394C (en) Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent
PL318043A1 (en) Complex compounds of a cascade polymer, method of obtaining them and pharmaceutic agents containing such compounds
JPS57159749A (en) N-(2,2,2-trifluoroethyl)-n-alkyl-azolyloxyacetic acid amides, manufacture, use as herbicide and novel intermediate
HUT49846A (en) Process for producing n-(3&#39;,4&#39;-dimethoxycinnamoyl)-anthranilic acid (tranilast)
ES2107562T3 (en) ALPHA-ARYL-ALPHA-HYDROXY-BETA-IMIDAZOLINYL-PROPANIC ACID AMIDES.
Mlynarczyk et al. Studies on acute toxicity of some new fungicides and insecticides designed for use in building industry. Part I. Intragastric acute toxicity.